Overview

Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma

Status:
Recruiting

Trial end date:
2023-12-31

Target enrollment:

Participant gender:

Summary

Compare the efficacy and tolerability of IRE in combination with either FOLFIRINOX or gemcitabine in patients with locally advanced pancreatic cancer.

Phase:

Phase 1

Details

Lead Sponsor:

University of Louisville

Treatments:

Folfirinox
Gemcitabine